SummerHaven Investment Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,285
| Closed | -$112K | – | 216 |
|
|
2023
Q2 | $112K | Sell |
15,285
-11,715
| -43% | -$86.1K | 0.07% | 194 |
|
|
2023
Q1 | $280K | Buy |
27,000
+1,653
| +7% | +$17.1K | 0.16% | 197 |
|
|
2022
Q4 | $299K | Buy |
25,347
+914
| +4% | +$10.8K | 0.18% | 199 |
|
|
2022
Q3 | $513K | Buy |
24,433
+9,957
| +69% | +$209K | 0.36% | 193 |
|
|
2022
Q2 | $449K | Hold |
14,476
| – | – | 0.3% | 170 |
|
|
2022
Q1 | $594K | Buy |
14,476
+662
| +5% | +$27.2K | 0.34% | 177 |
|
|
2021
Q4 | $600K | Hold |
13,814
| – | – | 0.32% | 193 |
|
|
2021
Q3 | $692K | Buy |
+13,814
| New | +$692K | 0.41% | 187 |
|